Flunarizine
Evidence-based neurology checklist on flunarizine: Pharmacology Flunarizine is a selective calcium channel blocker It has a long half life Migraine indications Non-migraine indications Dose Adverse effects
Pharmacology
- Flunarizine is a selective calcium channel blocker
- It has a long half life
Migraine indications
Non-migraine indications
Dose
Adverse effects
References
- Karsan N, Palethorpe D, Rattanawong W, Marin JC, Bhola R, Goadsby PJ. Flunarizine in migraine-related headache prevention: results from 200 patients treated in the UK. Eur J Neurol 2018; 25:811-817.
- Holmes B, Brogden RN, Heel RC, Speight TM, Avery GS. Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs 1984; 27:6-44.
- Rashid SMU, Sumaria S, Koohi N, Arshad Q, Kaski D. Patient experience of flunarizine for vestibular migraine: single centre observational study. Brain Sci 2022; 12:415.
